School of Pharmacy

Publications in the Biomolecular Science and Medicinal Chemistry Division

Publications

Content
BAGLIA, F. A., SHRIMPTON, C. N., EMSLEY, J., KITAGAWA, K., RUGGERI, Z. M., LOPEZ, J. A. and WALSH, P. N., 2004. Factor XI Interacts with the Leucine-rich Repeats of Glycoprotein Ibalpha on the Activated Platelet Journal of Biological Chemistry. VOL 279(NUMB 47), 49323-49329

Content
MATSUDA, S., HARRIES, J.C., VISKADURAKI, M., TROKE, P.J.F., KINDLE, K.B., RYAN, C. and HEERY, D.M., 2004. A conserved α-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP Journal of Biological Chemistry. 279(14), 14055-14064

Content
BELLODI, C., KINDLE, K., BERNASSOLA, F., DINSDALE, D., MELINO, G., COSSARIZZA, A., HEERY, D. and SALOMONI, P., 2004. Mutant PML Proteins Form Novel Cytoplasmic Bodies. (Poster # 764-III) BLOOD -NEW YORK-. VOL 104(NUMB 11), 3494

Content
WANG, S., MEADES, C., WOOD, G., OSNOWSKI, A., ANDERSON, S., YUILL, R., THOMAS, M., MEZNA, M., JACKSON, W., MIDGLEY, C., GRIFFITHS, G., FLEMING, I., GREEN, S., MCNAE, I., WU, S.Y., MCINNES, C., ZHELEVA, D., WALKINSHAW, M.D. and FISCHER, P.M., 2004. 2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activity Journal of Medicinal Chemistry. 47(7), 1662-1675

Content
MCINNES, C., WANG, S., ANDERSON, S., O'BOYLE, J., JACKSON, W., KONTOPIDIS, G., MEADES, C., MEZNA, M., THOMAS, M., WOOD, G., LANE, D.P. and FISCHER, P.M., 2004. Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors Chemistry & Biology. 11(4), 525-534

Content
WANG, S., WOOD, G., MEADES, C., GRIFFITHS, G., MIDGLEY, C., MCNAE, I., MCINNES, C., ANDERSON, S., JACKSON, W., MEZNA, M., YUILL, R., WALKINSHAW, M. and FISCHER, P.M., 2004. Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitors Bioorganic and Medicinal Chemistry Letters. VOL 14(NUMBER 16), 4237-4240

Content
FISCHER, P.M., 2004. The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases. Current Medicinal Chemistry. 11(12), 1563-1583

Content
FISCHER, P.M., 2004. The Use of CDK Inhibitors in Oncology: A Pharmaceutical Perspective Cell Cycle. VOL 3(ISSU 6), 742-746

Content
FISCHER, P.M., GLOVER, D.M. and LANE, D.P., 2004. Targeting the cell cycle Drug Discovery Today. VOL 1(NUMBER 4), 417-423

Content
FISCHER, P.M. and LANE, D.P., 2004. Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets? Trends in Pharmacological Sciences. 25(7), 343-346

Content
POONDRA, R.R., FISCHER, P.M. and TURNER, N.J., 2004. Efficient Palladium-Catalyzed Cross-Coupling of beta-Chloroalkylidene/arylidene Malonates Using Microwave Chemistry Journal of Organic Chemistry. VOL 69(NUMB 20), 6920-6922

Content
RAYNAUD, F.I., FISCHER, P.M., NUTLEY, B.P., GODDARD, P.M., LANE, D.P. and WORKMAN, P., 2004. Cassette dosing pharmacokinetics of a library of 2,6,9-trisubstituted purine cyclin-dependent kinase 2 inhibitors prepared by parallel synthesis. Molecular Cancer Therapeutics. 3(3), 353-362

Content
ANDREWS, M.J.I., MCINNES, C., KONTOPIDIS, G., INNES, L., COWAN, A., PLATER, A. and FISCHER, P.M., 2004. Design, synthesis, biological activity and structural analysis of cyclic peptide inhibitors targeting the substrate recruitment site of cyclin-dependent kinase complexes. Organic and Biomolecular Chemistry. 2(19), 2735-2741

Content
FISCHER, P.M., 2004. Apoptosis and Chemotherapy: Helping Cancer Cells to Die European BioPharmaceutical Review. Summer, 78-84

Content
LANE, D.P. and FISCHER, P.M., 2004. Drug development: Turning the key on p53 Nature. ISSU 6977, 789-790
Displaying 676 to 690 of 914
Previous … 44 45 46 47 48 … Next

School of Pharmacy

University of Nottingham
University Park
Nottingham, NG7 2RD

For all enquiries please visit:
www.nottingham.ac.uk/enquiry